Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tauzin’s First Steps: Play Up Patient Assistance, Tone Down Annual Meeting

Executive Summary

The Pharmaceutical Research & Manufacturers of America will hold its first annual meeting of the Tauzin era in Washington, D.C

You may also be interested in...

PhRMA CEO Tauzin Takes Over Jan. 3: PR Focus Begins At The Top

PhRMA's new management team under CEO Billy Tauzin will place a high priority on communications and partnerships with other stakeholders in healthcare policy debates

Medicare Rx Sponsors Must Notify CMS Of Part D Intentions In February

Potential Medicare Rx plan sponsors will need to tell the Centers for Medicare & Medicaid Services how they intend to participate in the Part D benefit by early February

PhRMA Agenda For 2005 Includes Medicare Start-Up, Liability Reform

The Pharmaceutical Research & Manufacturers of America will be supporting medical malpractice reform measures at the state level as part of its agenda for 2005

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts